Platinum-based neoadjuvant chemotherapy for triple-negative breast cancer: a systematic review and meta-analysis

BACKGROUND: Triple-negative breast cancer (TNBC) is associated with higher aggressiveness and mortality than hormone-positive breast cancer because of the lack of approved therapeutic targets. Patients with TNBC who attain a pathological complete response (pCR) after neoadjuvant chemotherapy have im...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhen-Yu, Zhang, Zhen, Cao, Xiao-Zhong, Feng, Yun, Ren, Sha-Sha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645412/
https://www.ncbi.nlm.nih.gov/pubmed/33100072
http://dx.doi.org/10.1177/0300060520964340

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645412/
https://www.ncbi.nlm.nih.gov/pubmed/33100072
http://dx.doi.org/10.1177/0300060520964340

Ejemplares similares